Your browser is no longer supported. Please, upgrade your browser.
Settings
FLXN Flexion Therapeutics, Inc. daily Stock Chart
FLXN [NASD]
Flexion Therapeutics, Inc.
Index- P/E- EPS (ttm)-3.52 Insider Own0.50% Shs Outstand39.79M Perf Week-0.90%
Market Cap962.52M Forward P/E- EPS next Y-4.03 Insider Trans7.03% Shs Float37.04M Perf Month0.12%
Income-110.10M PEG- EPS next Q-1.11 Inst Own- Short Float27.95% Perf Quarter1.72%
Sales- P/S- EPS this Y-31.90% Inst Trans23.17% Short Ratio11.67 Perf Half Y5.68%
Book/sh5.44 P/B4.45 EPS next Y-1.80% ROA-38.10% Target Price38.80 Perf Year25.08%
Cash/sh8.42 P/C2.87 EPS next 5Y- ROE-60.30% 52W Range16.51 - 32.25 Perf YTD-3.39%
Dividend- P/FCF- EPS past 5Y-29.60% ROI- 52W High-24.99% Beta0.77
Dividend %- Quick Ratio12.90 Sales past 5Y- Gross Margin- 52W Low46.52% ATR1.41
Employees95 Current Ratio12.90 Sales Q/Q- Oper. Margin- RSI (14)52.96 Volatility6.09% 6.26%
OptionableYes Debt/Eq0.92 EPS Q/Q-65.70% Profit Margin- Rel Volume0.65 Prev Close24.58
ShortableYes LT Debt/Eq0.87 EarningsMar 08 AMC Payout- Avg Volume886.96K Price24.19
Recom1.70 SMA204.13% SMA50-0.48% SMA2005.53% Volume579,465 Change-1.59%
Oct-09-17Reiterated Needham Buy $36 → $42
Aug-24-17Initiated Northland Capital Outperform
Dec-22-16Initiated Raymond James Strong Buy
Sep-06-16Resumed Lake Street Buy $38
Jul-21-16Initiated Lake Street Buy $38
May-03-16Resumed Wells Fargo Outperform
Nov-04-15Initiated Cantor Fitzgerald Buy
Sep-09-15Reiterated Needham Buy $31 → $28
May-14-15Initiated Northland Capital Outperform $40
Mar-31-15Initiated MLV & Co Buy $38
Aug-14-14Initiated Summer Street Research Buy $25
Mar-10-14Initiated Needham Buy $26
Feb-14-18 04:30PM  Flexion Therapeutics to Present at the RBC Capital Markets 2018 Global Healthcare Conference GlobeNewswire
Feb-08-18 07:55AM  New Research: Key Drivers of Growth for Radian Group, Flexion Therapeutics, Andeavor, Haverty Furniture Companies, Ares Capital, and Sempra Energy Factors of Influence, Major Initiatives and Sustained Production GlobeNewswire
Feb-02-18 04:30PM  Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Jan-08-18 07:30AM  Flexion Therapeutics Announces Initial Data from Clinical Trial Evaluating Repeat Administration of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) GlobeNewswire
Dec-29-17 09:00PM  3 Biotechs Launching Their First Commercial Drugs in 2018 Motley Fool
03:00AM  Flexion Therapeutics Getting Closer To Key Technical Measure Investor's Business Daily
Dec-18-17 04:05PM  Flexion Therapeutics Enrolls First Patient in Study Evaluating the Pharmacokinetics and Safety of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) in Osteoarthritis of the Shoulder and Hip GlobeNewswire
Dec-13-17 04:05PM  Flexion Therapeutics Announces Acquisition of Novel, Non-Opioid Asset for Osteoarthritis of the Knee GlobeNewswire
Dec-11-17 04:05PM  Flexion Therapeutics Announces Appointment of Scott Kelley, M.D. as Chief Medical Officer GlobeNewswire
Dec-10-17 07:16PM  2018 Is a Critical Year for These 3 Small Commercial-Stage Biotech Stocks Motley Fool
Dec-07-17 04:35PM  Flexion Therapeutics Enrolls First Patient in Phase 2 Pharmacokinetics and Safety Study of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) in Bilateral Osteoarthritis of the Knee GlobeNewswire
Dec-06-17 04:30PM  Flexion Therapeutics to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference GlobeNewswire
Dec-04-17 04:30PM  Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) GlobeNewswire
Nov-30-17 05:01PM  Flexion's (FLXN) Zilretta Therapy to Fast Capture OA Market Zacks
Nov-29-17 03:00AM  Stocks To Watch: Flexion Therapeutics Sees RS Rating Jump To 83 Investor's Business Daily
Nov-28-17 04:05PM  Flexion Therapeutics to Present at Evercore ISI 2017 Biopharma Catalyst/Deep Dive Conference GlobeNewswire
11:58AM  Biotech Pullback Makes Bargains Out Of Alexion, Flexion, Clovis, Tesaro And Incyte Forbes
07:14AM  This Small-Cap Biotech Stock Is Onto Something Big Motley Fool
Nov-27-17 08:00AM  Today's Research Reports on Stocks to Watch: Flexion Therapeutics and Teva Pharmaceutical ACCESSWIRE -7.03%
Nov-20-17 07:30AM  Flexion Therapeutics Announces Full Commercial Launch and Nationwide Availability of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) GlobeNewswire
Nov-17-17 09:00AM  Flexion Therapeutics Named Top Place to Work for 2017 by The Boston Globe GlobeNewswire
Nov-08-17 08:41PM  Edited Transcript of FLXN earnings conference call or presentation 6-Nov-17 9:30pm GMT Thomson Reuters StreetEvents
Nov-07-17 01:23PM  Is There Now An Opportunity In Flexion Therapeutics Inc (FLXN)? Simply Wall St.
Nov-06-17 05:07PM  Flexion Therapeutics reports 3Q loss Associated Press
04:05PM  Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights GlobeNewswire
03:00AM  Flexion Therapeutics Getting Closer To Key Technical Measure Investor's Business Daily
Nov-02-17 04:05PM  Flexion Therapeutics Highlights Two Clinical Data Presentations at the 2017 American College of Rheumatology Annual Meeting GlobeNewswire
Oct-30-17 04:05PM  Flexion Therapeutics to Report Third-Quarter 2017 Financial Results on November 6, 2017 GlobeNewswire
Oct-25-17 01:18PM  Stocks on My Radar on This Selling TheStreet.com -5.68%
Oct-17-17 01:55PM  Applied Optoelectronics, Helios And Matheson Among The Top Stocks With Short Sellers Benzinga
Oct-15-17 05:00PM  Flexion's Latest FDA Approval Reignites Takeover Chatter TheStreet.com
Oct-13-17 01:15AM  A New FDA Approval Sends Small Cap Flexion Soaring Motley Fool
Oct-11-17 05:55PM  Flexion Therapeutics Announces Pricing of Public Offering of Common Stock GlobeNewswire
09:23AM  Flexion Shares Lower After Proposed Stock Offering -- Biotech Movers TheStreet.com
Oct-10-17 04:05PM  Flexion Therapeutics Announces Proposed Public Offering of Common Stock GlobeNewswire
Oct-09-17 04:19PM  Flexion CEO: Absolutely thinking about exploring additional uses for new non-opioid drug CNBC -5.65%
02:33PM  Flexion CEO on non-opioid knee pain treatment CNBC Videos
10:15AM  Flexion's Zilretta Gets FDA Approval for Knee Pain, Stock Up Zacks
09:21AM  Flexion Shares Continue Rise After FDA Approval -- Biotech Movers TheStreet.com
09:00AM  Flexion Can Double Now That FDA Has Approved Zilretta Forbes
08:51AM  Flexion Therapeutics (FLXN) in Focus: Stock Moves 10.4% Higher Zacks
07:00AM  Flexion Therapeutics to Hold Conference Call at 8:00 a.m. ET to Discuss Recent FDA Approval of ZILRETTA (triamcinolone acetonide extended-release injectable suspension) PR Newswire
03:00AM  Flexion Therapeutics Clears Technical Benchmark, Hitting 90-Plus RS Rating Investor's Business Daily
Oct-07-17 10:20AM  Flexion shares surge on FDA approval for its non-opioid knee pain medication MarketWatch
Oct-06-17 04:30PM  Flexion's knee pain drug gets FDA nod, shares hit life high Reuters +10.36%
04:26PM  This Biotech Could Reap North Of $1 Billion For Painkiller Investor's Business Daily
04:12PM  Edited Transcript of FLXN earnings conference call or presentation 4-May-17 8:30pm GMT Thomson Reuters StreetEvents
03:45PM  Flexion Secures FDA Nod for Osteoarthritis Knee Pain Treatment, Shares Skyrocket TheStreet.com
03:42PM  Flexion soars on FDA drug approval CNBC Videos
03:25PM  Burlington biotech Flexion eyes expansion after FDA approves pain drug American City Business Journals
03:23PM  Flexion shares surge 18% on news of FDA approval for non-opioid knee pain injection MarketWatch
03:07PM  Flexion's knee pain drug gets FDA nod Reuters
03:00PM  Flexion Therapeutics Announces FDA Approval of Zilretta (triamcinolone acetonide extended-release injectable suspension) for Osteoarthritis (OA) Knee Pain GlobeNewswire
09:27AM  Paratek Shares Higher on Microbiology Data -- Biotech Movers TheStreet.com
03:00AM  Flexion Therapeutics Hits 80-Plus Relative Strength Rating Benchmark Investor's Business Daily
Oct-05-17 02:35PM  Big Day on Deck for Flexion Therapeutics Motley Fool
07:16AM  What You Must Know About Flexion Therapeutics Incs (FLXN) Risks Simply Wall St.
Oct-04-17 08:05AM  Outlook for FDA Approval of Zilretta ACCESSWIRE
Oct-03-17 08:14AM  The Zacks Analyst Blog Highlights: Flexion Therapeutics, Alexion Pharmaceuticals, PTC Therapeutics, Johnson & Johnson and TESARO Zacks
03:00AM  Stocks Showing Rising Market Leadership: Flexion Therapeutics Earns 85 RS Rating Investor's Business Daily
Oct-02-17 09:11AM  3 Biotech and Pharma Stocks with Key FDA Catalysts this October Zacks +8.52%
Sep-29-17 03:00AM  Flexion Therapeutics Sees Relative Strength Rating Improve To 75 Investor's Business Daily
Sep-19-17 08:36AM  Implied Volatility Surging for Flexion Therapeutics (FLXN) Stock Options Zacks
Sep-07-17 07:30AM  Flexion Therapeutics to Present Data on Zilretta (FX006) at PAINWeek 2017 GlobeNewswire
Aug-30-17 07:30AM  Flexion Therapeutics to Present at the 2017 Wells Fargo Healthcare Conference GlobeNewswire
Aug-25-17 01:30PM  'Date' These Potential Biotech Winners TheStreet.com
Aug-13-17 07:26AM  Edited Transcript of FLXN earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-17 11:57PM  Flexion Therapeutics reports 2Q loss Associated Press
04:05PM  Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights GlobeNewswire
11:10AM  Investor Network: Flexion Therapeutics, Inc. to Host Earnings Call ACCESSWIRE
Aug-07-17 02:06PM  Why Flexion Therapeutics Shares Shot 12.8% Higher in July Motley Fool
Aug-02-17 01:54PM  3 Exciting Biotechs Under $30: Flexion Therapeutics' Response to the Opioid Epidemic Motley Fool
08:15AM  3 Biotech Stocks With Big News Coming Motley Fool
Aug-01-17 07:30AM  Flexion Therapeutics to Report Second-Quarter 2017 Financial Results on August 8, 2017 GlobeNewswire
Jul-31-17 10:07AM  3 Hot Healthcare Stocks Under $30 Motley Fool -5.39%
Jul-18-17 09:30AM  The Zacks Analyst Blog Highlights: Valeant Pharmaceuticals International, Flexion Therapeutics, Ignyta and Anika Therapeutics Zacks
Jul-17-17 09:26AM  4 Sell-Ranked Drug Stocks to Avoid Ahead of Q2 Earnings Zacks
Jul-10-17 09:25AM  Flexion Therapeutics to Hold Investor & Analyst Day Today GlobeNewswire
Jul-06-17 09:00PM  Why Flexion Therapeutics Rallied 18% in June Motley Fool
Jul-05-17 04:27PM  Biotechs Gained $1.7 Billion Last Week Can They Keep Going? Investor's Business Daily +5.88%
Jul-03-17 07:30AM  Flexion Therapeutics to Hold Investor and Analyst Day on July 10, 2017 GlobeNewswire
Jun-28-17 07:30AM  Flexion Therapeutics Announces Appointment of Mark Levine as General Counsel GlobeNewswire
Jun-23-17 09:00AM  Flexion Therapeutics Named One of Boston Business Journals Best Places to Work GlobeNewswire
Jun-10-17 01:00PM  Flexion Therapeutics to Present Data on Zilretta (FX006) at the American Diabetes Associations 77th Scientific Sessions GlobeNewswire
May-23-17 01:47PM  Flexion CEO on developing an alternative to opioids CNBC Videos
May-22-17 07:30AM  Flexion to Present New Cost-Effectiveness Data on Zilretta (FX006) at the International Society for Pharmacoeconomics and Outcomes Research 22nd International Meeting GlobeNewswire +8.91%
May-18-17 07:30AM  Flexion Therapeutics Announces Upcoming Data Presentation at the American Diabetes Association's 77th Scientific Sessions GlobeNewswire
May-10-17 08:50PM  Another top executive at Sanofi Genzyme leaves company American City Business Journals
May-05-17 04:44PM  Edited Transcript of FLXN earnings conference call or presentation 4-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-04-17 06:33PM  Flexion Therapeutics reports 1Q loss Associated Press
04:01PM  Flexion Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights GlobeNewswire
09:45AM  Investor Network: Flexion Therapeutics, Inc. to Host Earnings Call Accesswire
May-01-17 07:30AM  Flexion Therapeutics to Present at the Deutsche Bank 42nd Annual Health Care Conference GlobeNewswire
Apr-28-17 07:30AM  Flexion Therapeutics Highlights Two Clinical Data Presentations at the Osteoarthritis Research Society International 2017 World Congress GlobeNewswire
Apr-26-17 07:04PM  Flexion Therapeutics Announces Pricing of $175 Million 3.375% Convertible Senior Notes due 2024 GlobeNewswire -20.65%
11:39AM  Why Flexion Therapeutics Inc. Stock Is Tanking Motley Fool
09:27AM  Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka TheStreet.com
Apr-25-17 04:01PM  Flexion Therapeutics Announces Proposed Convertible Senior Notes Offering GlobeNewswire
07:30AM  Flexion Therapeutics to Report First-Quarter 2017 Financial Results on May 4, 2017 GlobeNewswire
Apr-19-17 12:25PM  Why Flexion Therapeutics' New Pain Drug Could Be a Game-Changer Motley Fool
Flexion Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, a late-stage, intra-articular, extended-release investigational steroid treatment that has completed Phase 3 clinical trials for IA therapy for patients with moderate and severe osteoarthritis pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bodick NeilChief Scientific OfficerNov 21Buy24.661,00024,6561,000Nov 22 05:28 PM
Bodick NeilChief Scientific OfficerNov 21Buy24.391,70041,45764,605Nov 22 05:28 PM
Clayman Michael D.President and CEONov 08Buy23.605,000118,00035,395Nov 09 09:13 AM
Deniz YamoChief Medical OfficerSep 05Buy24.201,00024,2009,000Sep 15 05:12 PM
Deniz YamoChief Medical OfficerSep 01Buy24.153,00072,4508,000Sep 15 05:12 PM
Deniz YamoChief Medical OfficerAug 31Buy25.401,37534,9255,000Sep 15 05:12 PM
Stejbach MarkDirectorJun 16Buy17.021,58026,8881,580Jun 20 04:24 PM
COLELLA SAMUEL DDirectorJun 05Buy17.015,00085,0485,000Jun 06 06:49 PM
Clayman Michael D.President and CEOJun 05Buy17.235,00086,15220,146Jun 06 06:47 PM
Bodick NeilChief Medical OfficerMay 15Sale18.956,830129,44839,107May 17 04:15 PM
Bodick NeilChief Medical OfficerApr 17Sale28.235,000141,13245,937Apr 18 07:45 PM
DRISCOLL FREDERICK WChief Financial OfficerMar 23Option Exercise7.893,00023,65810,777Mar 24 04:24 PM
DRISCOLL FREDERICK WChief Financial OfficerMar 23Sale23.003,00069,0007,777Mar 24 04:24 PM
Bodick NeilChief Medical OfficerMar 17Sale20.415,000102,03950,937Mar 20 07:42 PM
DRISCOLL FREDERICK WChief Financial OfficerFeb 28Option Exercise7.8930,000236,58341,211Mar 02 04:56 PM
DRISCOLL FREDERICK WChief Financial OfficerFeb 28Sale19.9733,434667,6797,777Mar 02 04:56 PM
Bodick NeilChief Medical OfficerFeb 24Sale19.155,00095,75855,937Feb 27 04:17 PM